Lanean...
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
Dyslipidemia is a major risk factor for cardiovascular disease (CVD), which is the leading cause of morbidity and mortality in type 2 diabetes (T2DM). Statins have played a crucial role in its management, but residual risk remains since many patients cannot achieve their desired low-density lipoprot...
Gorde:
| Argitaratua izan da: | Diseases |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6023493/ https://ncbi.nlm.nih.gov/pubmed/29794992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases6020044 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|